NMN NICOTINAMIDE MONONUCLEOTIDE 500 MG

BIOGEN

#Other

Safety75

Efficacy70

Transparency80

Based on Examine, Wikipedia, and 23 other sources

Overview

This supplement provides Nicotinamide Mononucleotide (NMN) at a dose of 500mg, which aligns with amounts used in human clinical trials that have demonstrated effects on increasing NAD+ levels, improving physical ability, and impacting cardiovascular biomarkers. While promising, the extensive anti-aging claims associated with NMN are still in the early stages of human research. The inclusion of Organic Inulin Powder primarily supports digestive health and acts as a prebiotic, but its direct contribution to NMN's cellular and aging benefits is minimal.

The Good

Provides NMN at a research-backed dose (500mg daily) relevant for increasing NAD+.

NMN has demonstrated potential in human trials for improving physical ability and certain cardiovascular health markers.

Supports cellular NAD+ levels, which naturally decline with age, potentially contributing to cellular health and energy metabolism.

The Bad

Targeted for a very specific age group (70 years and older), which may not apply to all NMN consumers.

Long-term safety data in humans is still emerging for NMN, particularly at chronic and higher doses.

Potential for NMN to exacerbate chronic inflammation in certain contexts due to increased pro-inflammatory cytokines, though not yet observed in human trials.